Kelly A. Holmes

4.7k total citations · 2 hit papers
14 papers, 2.9k citations indexed

About

Kelly A. Holmes is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kelly A. Holmes has authored 14 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kelly A. Holmes's work include Estrogen and related hormone effects (9 papers), Genomics and Chromatin Dynamics (8 papers) and FOXO transcription factor regulation (3 papers). Kelly A. Holmes is often cited by papers focused on Estrogen and related hormone effects (9 papers), Genomics and Chromatin Dynamics (8 papers) and FOXO transcription factor regulation (3 papers). Kelly A. Holmes collaborates with scholars based in United Kingdom, United States and Australia. Kelly A. Holmes's co-authors include Jason S. Carroll, Caryn S. Ross-Innes, Antoni Hurtado, Dominic Schmidt, Gordon D. Brown, Simak Ali, Rory Stark, Carlo Palmieri, H. Raza Ali and Suet‐Feung Chin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Kelly A. Holmes

14 papers receiving 2.9k citations

Hit Papers

Differential oestrogen receptor binding is associated wit... 2010 2026 2015 2020 2012 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
    2012 1.3k citations Caryn S. Ross-Innes, Rory Stark et al. Nature profile →
  2. FOXA1 is a key determinant of estrogen receptor function and endocrine response
    2010 621 citations Antoni Hurtado, Kelly A. Holmes et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly A. Holmes United Kingdom 10 2.2k 905 640 512 261 14 2.9k
Caryn S. Ross-Innes United Kingdom 14 2.5k 1.2× 865 1.0× 669 1.0× 579 1.1× 366 1.4× 19 3.3k
Laura Corbo France 31 2.4k 1.1× 742 0.8× 555 0.9× 316 0.6× 157 0.6× 54 3.1k
Alexander S. Brodsky United States 24 2.8k 1.3× 1.0k 1.2× 608 0.9× 667 1.3× 335 1.3× 53 3.8k
Andrzej K. Bednarek Poland 28 1.9k 0.9× 1.2k 1.4× 619 1.0× 481 0.9× 216 0.8× 103 3.1k
Victor Sementchenko United States 14 3.1k 1.4× 858 0.9× 480 0.8× 988 1.9× 244 0.9× 15 3.8k
Martin Dutertre France 31 2.4k 1.1× 876 1.0× 351 0.5× 378 0.7× 158 0.6× 47 3.2k
Lily I. Huschtscha Australia 20 2.1k 1.0× 458 0.5× 1.1k 1.7× 595 1.2× 182 0.7× 26 3.0k
Howard H. Yang United States 28 2.1k 1.0× 484 0.5× 562 0.9× 641 1.3× 293 1.1× 81 2.9k
Xiaole Shirley Liu United States 19 2.6k 1.2× 445 0.5× 593 0.9× 802 1.6× 229 0.9× 25 3.3k
Gong‐Hong Wei China 23 2.3k 1.1× 423 0.5× 270 0.4× 520 1.0× 358 1.4× 75 3.0k

Countries citing papers authored by Kelly A. Holmes

Since Specialization
Citations

This map shows the geographic impact of Kelly A. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly A. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly A. Holmes more than expected).

Fields of papers citing papers by Kelly A. Holmes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly A. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly A. Holmes. The network helps show where Kelly A. Holmes may publish in the future.

Co-authorship network of co-authors of Kelly A. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly A. Holmes. A scholar is included among the top collaborators of Kelly A. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly A. Holmes. Kelly A. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gibson, Noula, et al.. (2024). Evaluating a developmental risk screening service for babies and young children with congenital heart disease following cardiac surgery. Progress in Pediatric Cardiology. 73. 101717–101717. 1 indexed citations
2.
Holmes, Kelly A., et al.. (2020). Interrater Reliability: Item Analysis to Develop Valid Questions for Case-Study Scenarios. Infection Control and Hospital Epidemiology. 41(S1). s303–s303. 2 indexed citations
3.
Papachristou, Evangelia K., et al.. (2019). Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha. PLoS ONE. 14(4). e0215340–e0215340. 8 indexed citations
4.
Nelson, Adam W, Arnoud Groen, Jodi L. Miller, et al.. (2016). Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity. Molecular and Cellular Endocrinology. 440. 138–150. 97 indexed citations
5.
Johnston, Simon J., Kelly A. Holmes, & Jason S. Carroll. (2016). Abstract 2906: Targeting FoxA1 in estrogen receptor-positive breast cancer: biological characterization of kinase regulators. Cancer Research. 76(14_Supplement). 2906–2906. 2 indexed citations
6.
Holmes, Kelly A., Gordon D. Brown, & Jason S. Carroll. (2015). Chromatin Immunoprecipitation-Sequencing (ChIP-seq) for Mapping of Estrogen Receptor-Chromatin Interactions in Breast Cancer. Methods in molecular biology. 1366. 79–98. 15 indexed citations
7.
Mohammed, Hisham, Clive S. D’Santos, Aurélien A. Sérandour, et al.. (2013). Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor. Cell Reports. 3(2). 342–349. 269 indexed citations
8.
Robinson, Jessica, Kelly A. Holmes, & Jason S. Carroll. (2013). FOXA1 mutations in hormone-dependent cancers. Frontiers in Oncology. 3. 20–20. 40 indexed citations
9.
Ross-Innes, Caryn S., Rory Stark, Andrew E. Teschendorff, et al.. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 481(7381). 389–393. 1304 indexed citations breakdown →
10.
Holmes, Kelly A., Antoni Hurtado, Gordon D. Brown, et al.. (2011). Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proceedings of the National Academy of Sciences. 109(8). 2748–2753. 42 indexed citations
11.
Hurtado, Antoni, Kelly A. Holmes, Caryn S. Ross-Innes, Dominic Schmidt, & Jason S. Carroll. (2010). FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genetics. 43(1). 27–33. 621 indexed citations breakdown →
12.
Ross-Innes, Caryn S., Rory Stark, Kelly A. Holmes, et al.. (2010). Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer. Genes & Development. 24(2). 171–182. 216 indexed citations
13.
Hurtado, Antoni, Kelly A. Holmes, Timothy R. Geistlinger, et al.. (2008). Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen. Nature. 456(7222). 663–666. 239 indexed citations
14.
Holmes, Kelly A., et al.. (2008). Nkx3-1 and LEF-1 Function as Transcriptional Inhibitors of Estrogen Receptor Activity. Cancer Research. 68(18). 7380–7385. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caryn S. Ross-Innes Breakdown of academic impact, for papers by Laura Corbo Breakdown of academic impact, for papers by Alexander S. Brodsky Breakdown of academic impact, for papers by Andrzej K. Bednarek Breakdown of academic impact, for papers by Victor Sementchenko Breakdown of academic impact, for papers by Martin Dutertre Breakdown of academic impact, for papers by Lily I. Huschtscha Breakdown of academic impact, for papers by Howard H. Yang Breakdown of academic impact, for papers by Xiaole Shirley Liu Breakdown of academic impact, for papers by Gong‐Hong Wei
Rankless by CCL
2026